Fasenra TV Ad Spend & Reach
×
Reach More AstraZeneca Patients Where They Watch
Your patients are watching TV. Are you reaching them?
The Challenge
Linear TV campaign in June
Ad Spend
$3,184,720
Missed Opportunity
68%
of target patients NOT reached
Only 32.1% reach rate = 4.8M at $658.00 per 1,000
You Missed 68% of Your Target Patients in June 2025.
Your linear TV campaign reached only 32.1% of the 15 million reachable patients - that’s just 4.8 million, at a cost of $658 per 1,000. This shortfall isn’t just a metric - it’s a gap between your message and those who need to hear it.
We know your patients are watching TV.
However, they are not being reached.
Nearly 10 Million Patients Went Unseen By Your Campaign.
Out of 15 million TV-reachable patients, your message never reached the remaining 68%. These are real individuals who fit your ideal profile but never had the chance to connect with your brand.
Your Competition Isn't Reaching Patients Either
Dupixent also struggles with patient reach
Dupixent Campaign
72% unreached = Missed patient opportunities
Even Your Competitors Face the Same Visibility Problem.
Dupixent’s campaign only achieved 28% reach, leaving 72% of potential patients unserved. When all players under-reach, those who break through first win the attention of tomorrow’s patients.
Maximize Your Patient Reach with TV+
TV+ dramatically expands your reach beyond current campaigns
TV+ Optimization Solution
Current reach: 32.1% (4.8M at $658.00/1K)
With TV+, You Can Increase Reach by 10% Using the Same Budget.
By layering linear and connected TV, TV+ taps into undervalued segments and reduces wasted exposure. Every additional patient reached strengthens brand recall, trust, and impact - making your spend work harder.
Ready to Reach More Patients?
See how TV+ can transform your pharma marketing with data-driven targeting and cross-channel optimization.
📊
Data-Driven Insights
🎯
Precision Targeting
💰
Budget Optimization
📺
Cross-Channel Reach
Let Simulmedia help you reach your audience
Get started with TV+ today
🔒 Your information is secure. We respect your privacy.
Data provided by Nielsen Ad Intel as of June 2025